Stress-induced conditions in the practice of primary care physicians
https://doi.org/10.21518/ms2025-083
Abstract
Anxiety disorders represent one of the most common groups of mental illness in the population and in general medical practice. These disorders can manifest in various forms and have a significant impact on the quality of life of patients, leading to increased morbidity and frequent calls for medical help. Psychoemotional disorders play an important role in the development and complicated course of various chronic non-communicable diseases, including cardiovascular diseases. The quality of life of patients significantly deteriorates, which leads to a decrease in physical activity, a deterioration in general well-being and, as a result, an increase in the number of adverse outcomes. On the other hand, there is an insufficient level of awareness among physicians of the risks associated with the psycho-emotional state of patients. Correction of psychoemotional disorders includes different approaches, both drug and non-drug methods of treatment are used. When choosing a drug, special attention is paid to several key factors, among which the most important are good tolerability of the drug, effectiveness and a high safety profile. A drug for the treatment of stress-induced psychovegetative syndrome in therapeutic doses should contribute to the rapid relief of autonomic dysfunction, restoration of sleep, effective reduction of elevated levels of anxiety, and improvement of the patient’s quality of life.
About the Authors
E. Yu. EbzeevaRussian Federation
Elizaveta Yu. Ebzeeva - Cand. Sci. (Med.), Associate Professor, Associate Professor of the Department of Therapy and Polymorbid Pathology named after Academician M.S. Vovsi.
2/1, Bldg. 1, Barrikadnaya St., Moscow, 125993
O. D. Ostroumova
Russian Federation
Olga D. Ostroumova - Dr. Sci. (Med.), Professor, Head of the Department of Therapy and Polymorbid Pathology named after Academician M.S. Vovsi, Russian Medical Academy of Continuous Professional Education; Professor of the Department of Clinical Pharmacology and Propaedeutics of Internal Medicine, Sklifosovsky Institute of Clinical Medicine, Sechenov First MSM U (Sechenov University).
2/1, Bldg. 1, Barrikadnaya St., Moscow, 125993; 11, Bldg. 1, Rossolimo St., Moscow, 119021
N. A. Plotnikova
Russian Federation
Natalia A. Plotnikova - Cand. Sci. (Med.), Associate Professor of the Department of Therapy and Polymorbid Pathology named after Academician M.S. Vovsi.
2/1, Bldg. 1, Barrikadnaya St., Moscow, 125993
S. V. Litvinova
Russian Federation
Svetlana V. Litvinova - Cand. Sci. (Med.), Assistant of the Department of Therapy and Polymorbid Pathology named after Academician M.S. Vovsi.
2/1, Bldg. 1, Barrikadnaya St., Moscow, 125993
T. V. Filippova
Russian Federation
Tatiana V. Filippova - Assistant of the Department of Therapy and Polymorbid Pathology named after Academician M.S. Vovsi.
2/1, Bldg. 1, Barrikadnaya St., Moscow, 125993
References
1. Kivimäki M, Kawachi I. Work Stress as a Risk Factor for Cardiovascular Disease. Curr Cardiol Rep. 2015;17(9):630. https://doi.org/10.1007/s11886015-0630-8.
2. Yaribeygi H, Panahi Y, Sahraei H, Johnston TP, Sahebkar A. The impact of stress on body function: A review. EXCLI J. 2017;16:1057–1072. https://doi.org/10.17179/excli2017-480.
3. Sokolov YeI, Ostroumova OD, Pervichko YeI, Guseva TF, Baryshnikova ZM. The psychological and hemodynamic features of patients with arterial hypertension under emotional stress. Arterial Hypertension (Russian Federation). 2005;11(1):29–33. (In Russ.) https://doi.org/10.18705/1607419X-2005-11-1-29-33.
4. Drapkina OM, Shishkova VM, Kotova MB. Psychoemotional risk factors for non-communicable diseases in outpatient practice. Guidelines for internists. Cardiovascular Therapy and Prevention (Russian Federation). 2022;21(10):3438. (In Russ.) https://doi.org/10.15829/1728-8800-2022-3438.
5. Härter M, Baumeister H, Reuter K, Jacobi F, Höfler M, Bengel J, Wittchen HU. Increased 12-month prevalence rates of mental disorders in patients with chronic somatic diseases. Psychother Psychosom. 2007;76(6):354–360. https://doi.org/10.1159/000107563.
6. Jha MK, Qamar A, Vaduganathan M, Charney DS, Murrough JW. Screening and Management of Depression in Patients with cardiovascular disease: JACC State-of-the-Art Review. J Am Coll Cardiol. 2019;73(14):1827–1845. https://doi.org/10.1016/j.jacc.2019.01.041.
7. Bandelow B, Michaelis S. Epidemiology of anxiety disorders in the 21st century. Dialogues Clin Neurosci. 2015;17(3):327–335. https://doi.org/10.31887/DCNS.2015.17.3/bbandelow.
8. Shishkova VN. Strategy for the management and prevention of psychoemotional disorders in the GP’s practice. Meditsinskiy Sovet. 2023;17(6):76–82. (In Russ.) https://doi.org/10.21518/ms2023-077.
9. Vorob’eva OV. Stress-induced psychovegetative reactions. RMJ. 2005;13(12):798-801. (In Russ.) Available at: https://www.rmj.ru/articles/obshchiestati/Stressinducirovannye_psihovegetativnye_reakcii/.
10. Pogosova NV, Boitsov SA, Oganov RG, Kostyuk GP, Sokolova OYu, Yufereva YuM et al. Psychosocial Risk Factors in Ambulatory Patients With Arterial Hypertension and Ischemic Heart Disease of 30 Cities in Russia: Data from the КОМЕТА (Сomet) Study. Kardiologiya. 2018;58(11):5–16. (In Russ.) https://doi.org/10.18087/cardio.2018.11.10193.
11. Boytsov SA, Pogosova NV, Bubnova MG, Drapkina OM, Gavrilova NE, Eganyan RA et al. Cardiovascular prevention 2017. National guidelines. Russian Journal of Cardiology. 2018;(6):7–122. (In Russ.) https://doi.org/10.15829/1560-4071-2018-6-7-122.
12. Смулевич АБ. Депрессии в общей медицине: руководство для врачей. М.: Медицинское информационное агентство; 2001. 782 с. Режим доступа: https://www.psychiatry.ru/lib/1/book/22.
13. Селье Г, Кандрор ВИ, Рогов АА, Дурмишьян МГ (ред.). Очерки об адаптационном синдроме. М.: Медгиз; 1960. 254 с. Режим доступа: https://djvu.online/file/F5CyMpbH98nY1.
14. Kotova ОV, Akarachkova ES, Belyaev AA. Psychovegetative syndrome: challenges in diagnosis and effective treatment. Meditsinskiy Sovet. 2018;(21):50–55. (In Russ.) https://doi.org/10.21518/2079-701X-2018-21-50-55.
15. Taylor DJ, Mallory LJ, Lichstein KL, Durrence HH, Riedel BW, Bush AJ. Comorbidity of chronic insomnia with medical problems. Sleep. 2007;30(2):213–218. https://doi.org/10.1093/sleep/30.2.213.
16. Cox RC, Olatunji BO. A systematic review of sleep disturbance in anxiety and related disorders. J Anxiety Disord. 2016;37:104–129. https://doi.org/10.1016/j.janxdis.2015.12.001.
17. Stein MB, Enns MW, Kryger MH. Sleep in nondepressed patients with panic disorder: II. Polysomnographic assessment of sleep architecture and sleep continuity. J Affect Disord. 1993;28(1):1–6. https://doi.org/10.1016/01650327(93)90071-q.
18. Alfano CA, Patriquin MA, De Los Reyes A. Subjective – Objective Sleep Comparisons and Discrepancies Among Clinically-Anxious and Healthy Children. J Abnorm Child Psychol. 2015;43(7):1343–1353. https://doi.org/10.1007/s10802-015-0018-7.
19. Ebzeeva EYu, Polyakova OA. Anxiety and sleep disorders. Meditsinskiy Sovet. 2022;16(11):108–113. (In Russ.) https://doi.org/10.21518/2079-701X-2022-16-11-108-113.
20. Poluektov M, Preobrazhenskaya I. Sleep and cognitive dysfunctions. Therapeutic approach. Neurology, Neuropsychiatry, Psychosomatics. 2014;(1):68–73. (In Russ.) https://doi.org/10.14412/2074-2711-2014-1-68-73.
21. Ковальзон ВМ. Основы сомнологии. Физиология и нейрохимия цикла «бодрствование–сон». М.: БИНОМ. Лаборатория знаний; 2012. 239 с. Режим доступа: https://psv4.userapi.com/s/v1/d/Hyf69HJjE9hWQI5PIInK8Bn1EtGY7wbx2e9LjqgEvXnz6vXRcmE0DdYNed4BK_QB1L2_ycmPF_XPxdo5y2MuAvHFLZ2pD8sHgrO2YgawcBLEglOL/Kovalzon_V_M_Osnovy_somnologii_fiziologia_i_neyrokhimia_tsikla_bodrstvovanie-son.pdf.
22. Вейн АМ, Вознесенская ТГ, Воробьева ОВ, Данилов АБ, Дюкова ГМ, Колосова ОА и др. Вегетативные расстройства: Клиника, диагностика, лечение. М.: МИА; 1998. 752 с. Режим доступа: https://psv4.userapi.com/s/v1/d/tLPIK38Iiwuwtzlz3eX2qTySFmWB0dryMC6xV-D5cZW-amF20zQkv32KbHZyMy5wz07yNrzvEaThI-xVjSX9i1S_-gAkpZnBEeti2rVBD3lsFyD/Vegetativnye_rasstroystva_Klinika_diagnostika_lechenie_Veyn_A_M.pdf.
23. Thorpy MJ. Classification of sleep disorders. Neurotherapeutics. 2012;9(4):687–701. https://doi.org/10.1007/s13311-012-0145-6.
24. Gordeev KS, Ermolaeva EL, Zhidkov AA, Ilyushina ES, Fedoseeva LA. Physiology of sleep and its impact on human brain function. Modern Scientific Researches and Innovations. 2018;(12). (In Russ.) Available at: https://web.snauka.ru/issues/2018/12/88012.
25. Levin YaI. Joys and Sorrows of Sleep. RMJ. 2008;27. (In Russ.) Available at: https://www.rmj.ru/articles/bolevoy_sindrom/Radosti_i_pechali_sna/.
26. Omisade A, Buxton OM, Rusak B. Impact of acute sleep restriction on cortisol and leptin levels in young women. Physiol Behav. 2010;99(5):651–656. https://doi.org/10.1016/j.physbeh.2010.01.028.
27. Pedersen SS, von Känel R, Tully PJ, Denollet J. Psychosocial perspectives in cardiovascular disease. Eur J Prev Cardiol. 2017;24(Suppl. 3):108–115. https://doi.org/10.1177/2047487317703827.
28. Cohen BE, Edmondson D, Kronish IM. State of the Art Review: Depression, Stress, Anxiety, and Cardiovascular Disease. Am J Hypertens. 2015;28(11):1295–1302. https://doi.org/10.1093/ajh/hpv047.
29. Heslop P, Smith GD, Carroll D, Macleod J, Hyland F, Hart C. Perceived stress and coronary heart disease risk factors: the contribution of socioeconomic position. Brit J Health Psychol. 2001;6(Pt 2):167–178. https://doi.org/10.1348/135910701169133.
30. Ng DM, Jeffery RW. Relationships between perceived stress and health behaviors in a sample of working adults. Health Psychol. 2003;22(6):638–642. https://doi.org/10.1037/0278-6133.22.6.638.
31. Кислицына ОА. Неравенство в распределении доходов и здоровья в современной России. М.: РИЦ ИСЭПН. 2005. 376 c.
32. Rimashevskaya NM, Kislitsyna OA. Income inequality and health. Narodonaselenie. 2004;(2):5–17. (In Russ.) Available at: http://www.kislitsyna.ru/data/files/narodonaselenie/2004%20Income%20inequality%20and%20health.pdf.
33. Layte R. The Association Between Income Inequality and Mental Health: Testing Status Anxiety, Social Capital, and Neo-Materialist Explanations. Eur Sociol Rev. 2012;28(4):498–511. Available at: https://www.jstor.org/stable/23272534.
34. Pickett KE, Wilkinson RG. Income inequality and health: A causal review. Soc Sci Med. 2015;128:316–326. https://doi.org/10.1016/j.socscimed.2014.12.031.
35. Mackenbach JP, Stirbu I, Roskam AJ, Schaap MM, Menvielle G, Leinsalu M, Kunst AE. Socioeconomic inequalities in health in 22 European countries. N Engl J Med. 2008;358(23):2468–2481. https://doi.org/10.1056/NEJMsa0707519.
36. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiat Scand. 1983;67(6):361–370. https://doi.org/10.1111/j.1600-0447.1983.tb09716.x.
37. Thompson DR, Ski CF. Psychosocial interventions in cardiovascular disease – what are they? Eur J Prev Cardiol. 2013;20(6):916–917. https://doi.org/10.1177/2047487313494031.
38. Краснов ВН, Вельтищев ДЮ, Бобров АЕ, Довженко ТВ. Расстройства аффективного спектра в общей медицинской практике (принципы терапии и партнерского взаимодействия психиатров и интернистов): методические рекомендации. М.: Национальный медицинский исследовательский центр психиатрии и наркологии имени В.П. Сербского; 2021. 32 с. Режим доступа: https://www.elibrary.ru/fmetnp.
39. Kutashev VA. Modern approach to the therapy for autonomic disorders in patients under stressful conditions. Meditsinskiy Sovet. 2018;(18):92–95. (In Russ.) https://doi.org/10.21518/2079-701X-2018-18-92-95.
40. Cases J, Ibarra A, Feuillere N, Roller M, Sukkar SG. Pilot trial of Melissa officinalis L. leaf extract in the treatment of volunteers suffering from mild-to-moderate anxiety disorders and sleep disturbances. Med J Nutrition Metab. 2011;4(3):211–218. https://doi.org/10.1007/s12349010-0045-4.
Review
For citations:
Ebzeeva EY, Ostroumova OD, Plotnikova NA, Litvinova SV, Filippova TV. Stress-induced conditions in the practice of primary care physicians. Meditsinskiy sovet = Medical Council. 2025;(3):145-150. (In Russ.) https://doi.org/10.21518/ms2025-083